Growth Metrics

Core Laboratories (CLB) Non-Current Deferred Tax Liability (2022 - 2026)

Core Laboratories filings provide 5 years of Non-Current Deferred Tax Liability readings, the most recent being $8.1 million for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 18.48% to $8.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.1 million, a 18.48% decrease, with the full-year FY2025 number at $8.0 million, down 11.81% from a year prior.
  • Non-Current Deferred Tax Liability hit $8.1 million in Q1 2026 for Core Laboratories, up from $8.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $22.9 million in Q4 2022 to a low of $8.0 million in Q4 2025.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $11.9 million (2023), compared with a mean of $12.0 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: tumbled 44.5% in 2023 and later rose 14.01% in 2024.
  • Core Laboratories' Non-Current Deferred Tax Liability stood at $22.9 million in 2022, then crashed by 44.5% to $12.7 million in 2023, then dropped by 28.6% to $9.1 million in 2024, then decreased by 11.81% to $8.0 million in 2025, then increased by 0.98% to $8.1 million in 2026.
  • The last three reported values for Non-Current Deferred Tax Liability were $8.1 million (Q1 2026), $8.0 million (Q4 2025), and $10.1 million (Q3 2025) per Business Quant data.